INTRODUCTION: Appropriateness of referrals for myocardial perfusion imaging (MPI) in developing countries has not been extensively studied. Our study was conducted to describe the ordering practices of physicians and appropriateness of MPI referrals in Iran. METHOD: We prospectively applied 2005 and 2009 versions of the Appropriateness Use Criteria published by the American College of Cardiology Foundation (ACCF) and the American Society of Nuclear Cardiology (ASNC) to 291 consecutive patients (age 55.3 ± 10.3 years) who underwent SPECT-MPI. For this purpose, we convened a panel, consisting of two academic cardiologists, one academic clinician in internal medicine, and one academic clinician in nuclear medicine. The panelists were invited for a face-to-face meeting to judge appropriateness of SPECT-MPI and independently assign a specific indication (scenario), whenever possible, for each case in accordance with ACCF/ASNC appropriateness scenarios. RESULTS: Based on the 2005 ACCF/ASNC criteria, SPECT-MPI studies were judged appropriate for 211 (72.5%), uncertain for 36 (12.4%), inappropriate for 32 (11.0%), and unclassifiable for 12 (4.1%) referrals. The same figures based on the 2009 version were 219 (75.3%), 15 (5.2%), 49 (16.8%), and 8 (2.7%) patients, respectively. Overall agreement between the 2005 and 2009 versions was good (κ 0.63). Lack of chest pain and age below 60 years were significant indicators increasing the likelihood of inappropriate referrals by 2.9-3.4 fold. Absence of diabetes mellitus and hypertension, a normal lipid profile, lack of a past history of myocardial infarction or cardiovascular interventions (CABGs or PCI), as well as lack of application and exercise ECG stress test as the gate keeper (keeping abnormal ETT or inability of the patient to perform exercise as the appropriate indication for SPECT-MPI referral) were significant indicators, decreasing the odds of appropriate referrals. Generally a higher percentage of referrals with inappropriate indications had normal MPI. CONCLUSION: Our study provides an evidence for the fact that SPECT-MPI ordering practices in our developing community largely parallel the ACCF/ASNC recommendations. The implementation of appropriateness criteria is feasible in clinical settings and might provide an alternative to utilization management.
INTRODUCTION: Appropriateness of referrals for myocardial perfusion imaging (MPI) in developing countries has not been extensively studied. Our study was conducted to describe the ordering practices of physicians and appropriateness of MPI referrals in Iran. METHOD: We prospectively applied 2005 and 2009 versions of the Appropriateness Use Criteria published by the American College of Cardiology Foundation (ACCF) and the American Society of Nuclear Cardiology (ASNC) to 291 consecutive patients (age 55.3 ± 10.3 years) who underwent SPECT-MPI. For this purpose, we convened a panel, consisting of two academic cardiologists, one academic clinician in internal medicine, and one academic clinician in nuclear medicine. The panelists were invited for a face-to-face meeting to judge appropriateness of SPECT-MPI and independently assign a specific indication (scenario), whenever possible, for each case in accordance with ACCF/ASNC appropriateness scenarios. RESULTS: Based on the 2005 ACCF/ASNC criteria, SPECT-MPI studies were judged appropriate for 211 (72.5%), uncertain for 36 (12.4%), inappropriate for 32 (11.0%), and unclassifiable for 12 (4.1%) referrals. The same figures based on the 2009 version were 219 (75.3%), 15 (5.2%), 49 (16.8%), and 8 (2.7%) patients, respectively. Overall agreement between the 2005 and 2009 versions was good (κ 0.63). Lack of chest pain and age below 60 years were significant indicators increasing the likelihood of inappropriate referrals by 2.9-3.4 fold. Absence of diabetes mellitus and hypertension, a normal lipid profile, lack of a past history of myocardial infarction or cardiovascular interventions (CABGs or PCI), as well as lack of application and exercise ECG stress test as the gate keeper (keeping abnormal ETT or inability of the patient to perform exercise as the appropriate indication for SPECT-MPI referral) were significant indicators, decreasing the odds of appropriate referrals. Generally a higher percentage of referrals with inappropriate indications had normal MPI. CONCLUSION: Our study provides an evidence for the fact that SPECT-MPI ordering practices in our developing community largely parallel the ACCF/ASNC recommendations. The implementation of appropriateness criteria is feasible in clinical settings and might provide an alternative to utilization management.
Authors: Ralph G Brindis; Pamela S Douglas; Robert C Hendel; Eric D Peterson; Michael J Wolk; Joseph M Allen; Manesh R Patel; Ira E Raskin; Robert C Hendel; Timothy M Bateman; Manuel D Cerqueira; Raymond J Gibbons; Linda D Gillam; John A Gillespie; Robert C Hendel; Ami E Iskandrian; Scott D Jerome; Harlan M Krumholz; Joseph V Messer; John A Spertus; Stephen A Stowers Journal: J Am Coll Cardiol Date: 2005-10-18 Impact factor: 24.094
Authors: Roger D Des Prez; Leslee J Shaw; Robert L Gillespie; Wael A Jaber; Gavin L Noble; Prem Soman; David G Wolinsky; Kim A Williams Journal: J Nucl Cardiol Date: 2005 Nov-Dec Impact factor: 5.952
Authors: Mohammad Palesh; Sten Fredrikson; Hamidreza Jamshidi; Pia Maria Jonsson; Goran Tomson Journal: Int J Technol Assess Health Care Date: 2007 Impact factor: 2.188
Authors: Robert C Hendel; Daniel S Berman; Marcelo F Di Carli; Paul A Heidenreich; Robert E Henkin; Patricia A Pellikka; Gerald M Pohost; Kim A Williams Journal: J Am Coll Cardiol Date: 2009-06-09 Impact factor: 24.094
Authors: O Lindner; W Burchert; F M Bengel; R Zimmermann; J Vom Dahl; W Schäfer; O Schober; R Kluge; M Schäfers Journal: Nuklearmedizin Date: 2008 Impact factor: 1.379
Authors: João V Vitola; Leslee J Shaw; Adel H Allam; Pilar Orellana; Amalia Peix; Annare Ellmann; Kevin C Allman; B N Lee; Chanika Siritara; Felix Y J Keng; Gianmario Sambuceti; Marla C Kiess; Raffaele Giubbini; Salaheddine E Bouyoucef; Zuo-Xiang He; Gregory S Thomas; Fernando Mut; Maurizio Dondi Journal: J Nucl Cardiol Date: 2009-07-22 Impact factor: 5.952
Authors: G Medolago; C Marcassa; A Alkraisheh; R Campini; A Ghilardi; R Giubbini Journal: Eur J Nucl Med Mol Imaging Date: 2014-03-15 Impact factor: 9.236
Authors: Mauro Augusto Dos Santos; Marisa Silva Santos; Bernardo Rangel Tura; Renata Félix; Adriana Soares X Brito; Andrea De Lorenzo Journal: J Nucl Cardiol Date: 2016-05-26 Impact factor: 5.952
Authors: Islam Y Elgendy; Ahmed Mahmoud; Jonathan J Shuster; Rami Doukky; David E Winchester Journal: J Nucl Cardiol Date: 2015-08-08 Impact factor: 5.952